That is very important, due to the fact that the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we need to know how these proteins fold if we want a drug to work. Historically, this has been a trial-and-error procedure (tech stocks). And now, Alpha, Fold can predict protein folding with 92. 4% accuracy. That's going to make it a lot easier to develop drugs that do what they're designed to do. This was an advancement practically no one discovered. But it's going to have extensive ramifications for treating illness. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be a lot of investment chances in this area, too. Shifting subjects It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown biotech stock). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be shocked if it pulled back possibly significantly before going higher - legacy report prediction. I've been covering bitcoin for a long time now. Among the very first research reports I ever published was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that preliminary suggestion, I entitled my report "What's the Big Offer With Bitcoin?" That shows you where the discussion was at the time. We were mainly educating readers. But that's not the huge concern any longer. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, specific niche business. Mass, Mutual is a relied on 170-year-old institution. So believe about that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a big factor I'm bullish on it this year. democratic republic. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These business raised a total of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of terrific private companies on the verge of hitting the general public markets And I've been working on a brand-new way for you to invest even prior to these companies go public.
This opportunity has actually been developing over the last few years. I can't wait to inform you everything about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Occasion to learn all the information. Go right here to reserve your spot for totally free.
Emma Walsh here, managing editor of the Diary. Regular Diary readers understand that tech isn't our typical beat (artificial intelligence). And when it comes to tech investing, we leave it to the experts. Luckily, we have numerous such specialists in our Rolodex. Our associate Jeff Brown will be familiar to our longtime readers. He is one of the most accomplished tech investing experts we understand (the legacy report prediction). In fact, he had numerous triple-digit returns in his Brownstone Research study portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to have a look at the big picture and anticipate what's just around the corner.
That includes things like 5G networks, biotech, artificial intelligence, and far more. These patterns are experiencing rapid development and creating unbelievable chances for investors. I wish to ensure all our readers are gotten ready for what's next. And with that in mind, let me draw the photo of what I see coming in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. longtime readers. But regardless of what lots of readers may think, this is a pattern that's just getting going. Despite the fact that the COVID-19 pandemic interrupted supply chains last year, an outstanding 250 million 5G-enabled gadgets were still offered.
And all of this ultimately led to Apple delaying the release of the 5G-enabled i, Phone 12 by two months (jeff bezos). Losing two months of manufacturing and sales really affects the number of 5G devices are offered in the fiscal year. When you think about all of that, offering 250 million units is exceptional. More importantly, the hold-ups brought on by the pandemic created a lot of suppressed demand. Which demand is now going to be pushed into 2021. In reality, I predict that more than 500 million 5G gadgets will be delivered in 2021 - genetic sequencing companies jeff brown. And that's not my only 5G prediction When I've talked about 5G in the past, I have actually explained its three different stages.
In Phase 2, 5G devices go on sale. 5G phones and other products start to reach customers. And in Stage Three, 5G services start to be offered (jeff brown investment prediction). That's when we start to see applications operating on 5G networks. Think of things like massive multiplayer video games over a smart phone. That's not possible with 4G. It will be with 5G. And my second 5G prediction for 2021 is that we will begin Stage Three by this summer season. This starts something of a virtuous cycle: Many people don't truly appreciate the technology. However they will care if there are interesting applications that can just be accessed with a 5G phone.
That results in more 5G apps being established. In truth, 5G is going to open up a suite of amazing applications: self-driving vehicles, the Internet of Things, robotic surgical treatment, and more. All of these technologies need 5G. The financial investment opportunities moving forward will be huge. Stepping far from 5G, the next essential innovation I visualize in 2021 is CRISPR genetic modifying. CRISPR represents "clustered regularly interspaced short palindromic repeat." It's a mouthful. But it is among the most exciting advancements in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software application.
The program can crash or not function correctly. CRISPR utilizes a similar idea but with our hereditary code. "Typos" in our genome can cause illness. CRISPR can fix these "typos." For many years, CRISPR was mainly a specific niche technology that wasn't well comprehended. And throughout that time, there were truly just three business operating in this space. However things are altering. CRISPR is no longer just theoretical. We're seeing actual results. We're treating illness and seeing that this technology just works. And as an outcome, a "second crop" of early-stage CRISPR companies is going public and delivering incredible returns. This whole industry is successfully a greenfield chance.
There's space for many companies to exist in this space. first lady. And there will be more. That's my prediction for CRISPR in 2021. I forecast that 2 or 3 more genetic modifying business will hold their IPOs. Sticking to biotechnology, we are seeing incredible things taking place at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply announced at the end of 2020 that its most current Alpha, Fold software can accurately anticipate the folding of a protein based solely on its amino acid series with 92. 4% accuracy. That's crucial because the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been an experimental procedure. However now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it much simpler to produce drugs that do what they're developed to do. And here's my next prediction. I predict that Alpha, Fold will be 98% accurate by the end of 2021. And we will see not just one but several drug therapies produced using this technology. This was among those developments that nearly no one observed. But it's going to have extensive implications for curing illness. And, of course, there will be lots of investment opportunities in this space, too.
It's going to be an excellent year for bitcoin. I'm bullish on it in 2021. That stated, I still think bitcoin will continue to be unpredictable. We're close to all-time highs. I would not be amazed if it drew back perhaps significantly prior to going higher. I have actually been covering bitcoin for a long period of time now. Among the first research study reports I ever released was on bitcoin - jeff brown predictions 2021. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ return on investment for anyone who followed my suggestion. But at the time of that preliminary suggestion, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
But nobody is asking that concern anymore. Now, we're seeing institutional money finally taking an interest in bitcoin. The big news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. jeff brown top biotech 2020. Mass, Mutual is a 150-year-old institution. So consider that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason that I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another bonus prediction In 2021, we're going to have another record year in IPOs. One website reports that Jeff Brown deserves about $27. 5 million and declares the details is up to date as of February 2021, however we might not separately confirm this claim. Given Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down an exact figure at this minute. Brown is best known for his sage-like capability to choose winning innovation stocks. He spent more than 25 years researching technology companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's extensive experience offers him an exceptional perspective on the market. He's constantly on the hunt for brand-new chances, and he shares a number of his best picks in the Future Report.
That's high appreciation, however it's not ridiculously reasoned. Brown has an excellent track record as a stock-picker, and he successfully forecasted a few of the greatest economic occasions of the previous twenty years. Although he does not appear to launch his picks to the general public, the service's success is a direct indication of Brown's stock-picking expertise. Nobody on Wall Street gets it right each time, however Jeff Brown's accurate predictions have earned him legions of devoted fans. That states a lot about his capability. The Future Report is published by Brownstone Research, a popular monetary research study publisher. Brownstone Research study provides a number of research study services with a wide array of specializations - jeff brown top stock pick 2021.
The company is likewise connected with Bonner & Partners, another well-respected research publisher - jeff brown biotech picks. On its website, Brownstone says its mission is to offer retail investors with professional-grade research: "For too long, the finest financial investment research study has actually not been readily available to specific financiers. It has actually been usually scheduled for investment banks, hedge funds, personal equity, and high-net-worth clients. tech predictions. The mission of Brownstone Research is to make that kind of proprietary research study available to any investors wanting to gain an edge in the markets. The goal is easy to deliver unique and successful financial investment research study discovered no place else." -Brownstone Research site excerpt from the Jeff Brown is the founder of Brownstone Research, and he likewise serves as the firm's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After years of stable success at the helm of top-tier business like Tesla and Area, X, Elon Musk is a home name throughout most of America. If you understand even a bit about the marketplace, you understand that he has a reputation as a King Midas of sorts. last week. Everything he touches relies on gold! Jeff is well mindful of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next relocation. This time, Jeff has an early lead on Elon's next big project.
In reality, Brown thinks S.A.V. biotech stocks. could be "the most significant pattern of the 2020s, and he's not alone. Examine out these quotes from other popular S.A.V. bulls: Elon's next huge act will be marrying 2 innovative innovations: expert system and electric cars and trucks. Musk hopes the mix will assist him establish the first fully-autonomous, self-driving cars and trucks ever. It's nothing except the automobile market's Holy Grail. As you know, electrical lorries and self-driving car stocks have been substantial this year, but the Wall Street device has been big on buzz without much concrete outcome. Despite a drastic increase in competition over the past few years, Brown still thinks Musk has the very best possibility of putting everything together.
tech could be the magic string that ties everything together. S.A.V. stands for Shared Autonomous Automobile, and it might be the future of transport. Basically, this technology would allow you to lease out your automobile as a self-governing, self-driving taxi when you're not using it. You merely leave the automobile and press a button on an app that informs the automobile to "sign up with the fleet." Next thing you know, you're relaxing on your sofa while your cars and truck shuttles ride-sharers around town. Most importantly, you get to keep a hefty portion of the revenues. It sounds outrageous, however it could be closed than you believe.